Concurrent radiation therapy

RADIATION3 trials

Conditions

Bladder CancerBrain and Central Nervous System TumorsCervical CancerEsophageal CarcinomaEsthesioneuroblastomaGlioblastoma MultiformeLarge Cell Neuroendocrine Carcinoma of the LungMedullary Thyroid Cancer

Phase 1

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

RecruitingNCT06814496

University of ArizonaBladder Cancer, Cervical Cancer, Esthesioneuroblastoma +8

Start: 2025-09-08End: 2030-05-01Target: 30Updated: 2026-07-20

Phase 2

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

CompletedNCT06048913

The First Affiliated Hospital with Nanjing Medical UniversityEsophageal Carcinoma

Start: 2020-12-01End: 2025-01-01Updated: 2025-07-04

Phase 3

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

CompletedNCT00304031

Radiation Therapy Oncology GroupBrain and Central Nervous System Tumors

Start: 2006-01-31End: 2016-12-31Updated: 2020-06-09

Related Papers

A phase 2 clinical study of nimotuzumab plus S-1 and concurrent radiotherapy in 75 years and older patients with esophageal squamous cell carcinoma.

Journal of Clinical Oncology2026-05-27

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.

2023-01-0112 citations

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era

JAMA Oncology2017-01-1795 citations